Impact of individualized nursing interventions on ventilator weaning and respiratory outcomes in ICU patients with severe pneumonia: A retrospective cohort study
Abstract
Severe pneumonia frequently necessitates intensive care, with mechanical ventilation serving as a cornerstone of treatment. Despite its life-saving benefits, ventilator weaning poses considerable challenges and is often associated with complications. This study evaluates the efficacy of a tailored nursing approach in enhancing weaning outcomes and accelerating pulmonary recovery. A retrospective analysis was conducted on 110 intensive care units (ICU) patients with severe pneumonia requiring mechanical ventilation at our institution between January 2022 and July 2024. Participants were stratified into 2 cohorts: an intervention group (n = 55) receiving individualized nursing care – encompassing rigorous disease surveillance, optimized airway management, and structured respiratory rehabilitation – and a control group (n = 55) managed with standard protocols. Key findings demonstrated superior clinical metrics in the intervention group, including faster resolution of fever (P < .05), reduced intensive care units (ICU) and hospital stays (P < .05), and shorter mechanical ventilation duration (P < .05). Notably, the intervention group achieved a 96.36% weaning success rate, significantly outperforming the control group’s 81.82% (P = .014). Adverse events were markedly lower in the intervention cohort (10.91% vs 40.00%, P = .003), alongside significantly higher patient satisfaction scores (P = .026). These results underscore that personalized nursing strategies substantially…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 55 participants or records.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.